IC
KALA icon

Ikarian Capital’s KALA BIO KALA Stock Holding History

Ikarian Capital’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-35
Closed -$594K – 316
2020
Q4 		$594K Sell
35
-146
-81% -$2.75M 0.03% 187
2020
Q3 		$3.39M Buy
+181
New +$4.16M 0.25% 85
2020
Q2 		– Sell
-198
Closed -$4.34M – 190
2020
Q1 		$4.34M Sell
198
-212
-52% -$3.39M 0.33% 70
2019
Q4 		$3.78M Buy
+410
New +$3.96M 0.61% 46

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital's KALA Position: Q1 2021 in Review

Ikarian Capital sold out of KALA BIO (KALA) in Q1 2021, closing a stake of 35 shares — an estimated $594K sold.

Ikarian Capital first reported a position in KALA in Q4 2019 and held it in 4 quarters. The position peaked at $4.34M in Q1 2020. 106 funds tracked by Wall St. Rank hold KALA as of Q1 2021.

  • Ikarian Capital reported no remaining KALA BIO position as of Q1 2021 after selling out during the quarter.
  • Ikarian Capital sold 35 KALA BIO shares in Q1 2021, an estimated $594K.
  • Ikarian Capital first reported a position in KALA BIO in Q4 2019 and held it in 4 quarters.
  • Ikarian Capital's KALA BIO position peaked at $4.34M in Q1 2020.
  • 106 funds tracked by Wall St. Rank held KALA BIO as of Q1 2021.

Based on Ikarian Capital's 13F filing for Q1 2021, filed 17 May 2021.